InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1 |
AOJJSUZBOXZQNB-TZSSRYMLSA-N |
COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO |
|
Escherichia coli
(NCBI:txid562)
|
See:
PubMed
|
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via anthracycline )
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via anthracycline antibiotic )
|
|
View more via ChEBI Ontology
(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside
|
doxorubicin
|
ChemIDplus
|
doxorubicine
|
ChemIDplus
|
doxorubicinum
|
ChemIDplus
|
(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside
|
ChEBI
|
(8S-cis)-10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
|
ChemIDplus
|
14-hydroxydaunomycin
|
ChemIDplus
|
14-hydroxydaunorubicine
|
ChemIDplus
|
Adriamycin
|
KEGG COMPOUND
|
Adriamycin
|
KEGG COMPOUND
|
Doxorubicin
|
KEGG COMPOUND
|
DOXORUBICIN
|
PDBeChem
|
960
|
DrugCentral
|
C01661
|
KEGG COMPOUND
|
D03899
|
KEGG DRUG
|
DB00997
|
DrugBank
|
DM2
|
PDBeChem
|
LMPK13050001
|
LIPID MAPS
|
LSM-4062
|
LINCS
|
View more database links |
23214-92-8
|
CAS Registry Number
|
KEGG COMPOUND
|
23214-92-8
|
CAS Registry Number
|
ChemIDplus
|
|